IDXX vs WAT
Idexx Laboratories and Waters Corporation, both Healthcare
Idexx Laboratories is the larger company at $44B against $35B. On trailing earnings IDXX is the cheaper of the two at a P/E of 36.4 against 108.2, a gap that is only a bargain if the two are growing at similar rates. Over the past year WAT returned +42% against -21% for IDXX. The RyuScore puts IDXX ahead, 70 against 49 out of 100.
| Figure | IDXX | WAT |
|---|---|---|
| Last close | $518 | $434 |
| Market cap | $44B | $35B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 36.4 | 108.2 |
| 1-year return | -21% | +42% |
| 5-year return | -21% | +7.6% |
| RyuScoresector-relative, 1–10 | 70/100 | 49/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Idexx Laboratories
Revenue of $1.2B in Q2 2026, net income $338M. Its largest reported line is Vet Lab Consumables, 35% of the disclosed total.
Waters Corporation
Revenue of $1.6B in Q2 2026, net income null. Its largest reported line is Consumables, 47% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.